Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07568119 · ClinicalTrials.gov registry record
Feasibility and Acceptance of SonoHeal for Airway Clearance and Preliminary Comparison With the Standard of Care
A clinical trial, sponsored by Cognita Labs.
- Active
- Registry status
- 15
- Enrollment target
NCT07568119: Active study, sponsored by Cognita Labs.
NCT07568119 is a clinical trial that is active but no longer recruiting, run by Cognita Labs. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07568119 is active but no longer recruiting, sponsored by Cognita Labs.
- ACTIVE NOT RECRUITING
- Registry status
- 15 participants
- Enrollment target
Study Summary
The proposed study is to gauge the early feasibility and acceptance of the SonoHeal device. The study will evaluate the usability of the SonoHeal prototype using well-established Human Factors Engineering methods recommended by the FDA. The investigators will also obtain a preliminary comparison with the standard of care ACT device, High Frequency Chest Wall Oscillation (HFCWO).
Primary Outcome
The patients will describe their experience during the therapy using the Cognitive Walk Through Evaluation
Interventions
- DEVICE Airway clearance therapy through acoustic oscillations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-02-17 |
| Est. Completion | 2026-06-30 |
What the registry record for NCT07568119 still lists
NCT07568119 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Airway clearance therapy through acoustic oscillations is the first listed.
NCT07568119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07568119 about?
NCT07568119 is a clinical study titled "Feasibility and Acceptance of SonoHeal for Airway Clearance and Preliminary Comparison With the Standard of Care". The proposed study is to gauge the early feasibility and acceptance of the SonoHeal device. The study will evaluate the usability of the SonoHeal prototype using well-established Human Factors Engineering methods recommended by the FDA. The investigators will also obtain a preliminary comparison wit...
What is the current status of trial NCT07568119?
This trial is currently active not recruiting. The enrollment target is 15 participants. The study started on 2024-02-17. Estimated completion is 2026-06-30.
What interventions are being tested in trial NCT07568119?
The interventions under investigation include: Airway clearance therapy through acoustic oscillations (DEVICE).
Who is sponsoring clinical trial NCT07568119?
This trial is sponsored by Cognita Labs, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI